CCL2 and breast carcinoma: Similarly, there were no significant changes in the cardiac transcript levels of the inflammatory markers interleukin 1β, interleukin 18, monocyte chemoattractant protein-1, Galectin-3 (Mac-2) (Figures 3E to 3H), or the number of Galectin-3 (Mac-2)–positive cells (Figures 3I and 3J) in all groups of our mouse model of breast cancer.